Arcadia Biosciences (NASDAQ:RKDA) Earns Sell Rating from Analysts at StockNews.com

StockNews.com began coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a research report report published on Sunday morning. The firm issued a sell rating on the basic materials company’s stock.

Separately, HC Wainwright reiterated a “buy” rating and issued a $6.00 target price on shares of Arcadia Biosciences in a research report on Wednesday, August 21st.

Arcadia Biosciences Stock Up 1.1 %

Arcadia Biosciences stock opened at $2.79 on Friday. Arcadia Biosciences has a 12-month low of $1.85 and a 12-month high of $5.34. The business’s 50-day moving average price is $3.32 and its two-hundred day moving average price is $3.07. The stock has a market cap of $3.79 million, a PE ratio of -0.65 and a beta of 1.27.

About Arcadia Biosciences

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.